Chemotherapy & More
- This forum has 1,151 topics, 3,414 replies, and was last updated 2 years ago by .
-
- Topic
- Voices
- Last Post
-
- An evaluation of ivosidenib for the treatment of IDH1-mutant cholangiocarcinoma
- 1
- 2 years, 1 month ago
- Micro-lymph node metastasis in intrahepatic cholangiocarcinoma showing pathologi
- 1
- 2 years, 1 month ago
- The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFI
- 1
- 2 years, 1 month ago
- FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally A
- 1
- 2 years, 1 month ago
- The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFI
- 1
- 2 years, 1 month ago
- Neoadjuvant therapy use and association with postoperative outcomes and overall
- 1
- 2 years, 1 month ago
- Successful treatment of stage IIIB intrahepatic cholangiocarcinoma using neoadju
- 1
- 2 years, 1 month ago
- A new promising oncogenic target (p.C382R) for treatment with pemigatinib in pat
- 1
- 2 years, 1 month ago
- A case of unresectable locally advanced intrahepatic cholangiocarcinoma that ach
- 1
- 2 years, 1 month ago
- Derazantinib Showed Clinical Benefit as a Second-Line Treatment for Patients Wit
- 1
- 2 years, 1 month ago
- Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS
- 1
- 2 years, 1 month ago
- The forum ‘Chemotherapy & More’ is closed to new topics and replies.